inspiremd.com - NSPR Profit before deduction of interest, taxes, depreciation and amortization
The industry is implementing advanced micro-mesh vascular protection systems, expanding its target markets. InspireMD, Inc. (NSPR) maintains the trust of surgeons due to the precision of CGuard devices, despite intense pressure from healthcare behemoths in an oligopolistic environment. The operating profit summary demonstrates the business's financial resilience, where the 0.00 metric determines this level, confirming the effective execution of the company's growth strategy.
Summary analytical data breakdowns for InspireMD (NSPR)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio InspireMD, Inc.|NSPR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio InspireMD Inc|NSPR - Company Aggregate Debts|Debts to Book Value InspireMD|NSPR - Company Long-Term Debts|Company Short-Term Indebtedness InspireMD|Interim Coverage Ratio inspiremd.com
- earnings and market multiples details:
NSPR - Net Profit|Future Profit InspireMD, Inc.|NSPR - P/E Multiple|Forward P/E Multiple inspiremd.com|NSPR - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InspireMD|NSPR - Operating profit before deduction of amortization|Earnings per share for the trailing year InspireMD|NSPR - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months inspiremd.com|NSPR - Earnings per share growth in current year|Net earnings per one share growth forecast for next year InspireMD, Inc.
Summary company analytics:InspireMD, Inc.
Absolute operating profit reflects the business's ability to generate cash flow from core operations before taxes and depreciation. By analyzing the calculated EBITDA, an investor assesses the scaling efficiency of CGuard stent sales and the pace of expansion within the US market. This indicator eliminates accounting distortions, revealing the actual profitability of the commercial launch of innovative medical devices by InspireMD, Inc. (NSPR).
Who InspireMD, Inc. competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Operating profit EBITDA|Operating income before deduction of amortization Anika Therapeutics ANIK|zhjmedical.com (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani Medical)|Profit before payment of interest, taxes and amortization Xtant Medical Holdings, Inc.|Operating profit before deduction of amortization NeuroOne Medical Technologies Corp. (NMTC)|Operating profit EBITDA MODD|MYO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Envoy Medical COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|TNON: Operating profit EBITDA|LFWD - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Autonomix Medical Inc.|Operating profit before amortization IVF (INVO Bioscience)|Profit before payment of interest, taxes and amortization Bone Biologics Corporation (BBLG)|Operating income before deduction of amortization Axonics, Inc|Profit before payment of interest, taxes and amortization BIOLASE, Inc. BIOL|DYNT (Dynatronics Corp) - Profit before deduction of interest, taxes, depreciation and amortization|Paragon 28 Corp - Operating profit EBITDA|Operating income before deduction of amortization INVO Bioscience, Inc. INVO
